Skip to main content

Find Clinical Trials

Home
Conditions
Stage IV Bladder Cancer

Clinical trial condition

Stage IV Bladder Cancer

Explore clinical trials studying Stage IV Bladder Cancer. Study availability and eligibility vary by location and protocol.

18 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Stage IV Bladder Cancer trial results

Completed

Pazopanib in Treating Patients With Metastatic Urothelial Cancer

NCT00471536

Conditions: Distal Urethral Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +18 more
Locations: Mayo Clinic in Florida Jacksonville, Florida, United States

Johns Hopkins University Baltimore, Maryland, United States

Wayne State University Detroit, Michigan, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma

NCT00072150

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +22 more
Locations: UCSF-Mount Zion San Francisco, California, United States

View Trial Details

Completed

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

NCT00004074

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Decitabine in Treating Patients With Advanced Solid Tumors

NCT00030615

Conditions: Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +30 more
Locations: University of Southern California Los Angeles, California, United States

View Trial Details

Completed

Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer

NCT00021099

Conditions: Distal Urethral Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +21 more
Locations: Eastern Cooperative Oncology Group Boston, Massachusetts, United States

View Trial Details

Completed

Gene Therapy in Treating Patients With Advanced Bladder Cancer

NCT00003167

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +14 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

NCT00030498

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +185 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

View Trial Details

Completed

Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer

NCT00005831

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +14 more
Locations: University of Michigan University Hospital Ann Arbor, Michigan, United States

View Trial Details